Riskpilot← Back to searchSign inGet full accessRemedium Aktiebolag
ABActiveOrg 5590981493Elementvägen 8Rental and operating of own or leased real estate · NACE 6820Est. 20170 employees
Revenue 2024
SEK 1,1M
+5% vs 2023
EBITDA margin
21.9%
-38% vs 2023
Equity ratio
62.0%
Financial strength
Net profit 2024
SEK 0
-100% vs 2023
| Revenue | SEK 1,1M | +5% |
| EBITDA | SEK 242K | -38% |
| Net profit | SEK 0 | -100% |
| Total assets | SEK 3,3M | +7% |
| Equity | SEK 2,1M | +0% |
| Employees | 0 | — |
Legal name
Remedium Aktiebolag
Org number
5590981493
Legal form
Aktiebolag
NACE code
6820 · Rental and operating of own or leased real estate
Founded
24 januari 2017
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva uthyrning och förvaltning av egna eller arrenderade industrilokaler.
Address
Elementvägen 8
Email
anders@w-invest.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 1 130 | 1 047 | 1 067 | 1 054 | 1 102 |
| Staff expenses | — | — | — | −0 | −0 |
| EBITDA | 523 | 320 | 385 | 389 | 242 |
| Depreciation & amort. | −10 | −10 | −10 | −10 | −8 |
| EBIT | 513 | 310 | 375 | 379 | 234 |
| Net financials | −4 | −3 | −4 | 3 | 2 |
| Profit before tax | 509 | 306 | 372 | 610 | 0 |
| Tax | −109 | −63 | −77 | −128 | — |
| Net profit | 400 | 243 | 295 | 482 | 0 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 2 238 | 2 597 | 2 776 | 3 088 | 3 318 |
| Equity | 1 035 | 1 279 | 1 574 | 2 056 | 2 056 |
| Long-term debt | 868 | 932 | 843 | 837 | 1 073 |
| Short-term debt | 108 | 160 | 132 | 195 | 189 |
| Total debt | 976 | 1 092 | 975 | 1 033 | 1 262 |
EBITDA margin
21.9%
This company
15.8%
Market median
+39% vs market
20202024
Equity ratio
62.0%
This company
38.2%
Market median
+62% vs market
20202024
Return on equity
0.0%
This company
18.4%
Market median
-100% vs market
20202024
Net profit margin
0.0%
This company
8.1%
Market median
-100% vs market
20202024
Asset turnover
0.33×
This company
1.12×
Market median
-71% vs market
20202024
Debt / equity
0.61×
This company
0.62×
Market median
+2% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
HO Audit | Audit | 2022 |
| Former (1) | ||
AJ External Signatory | External Signatory | 2022 – 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Remedium Aktiebolag also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Hans Oskar Olsson | Audit | 0 companies |
| Anders Jan Willerman | External Signatory | 0 companies |
| Kurt Anders Carlsson | Deputy Board Member | 0 companies |
| Johan Anders Willerman | Board of Directors | 0 companies |